NDC 51672-2144-01 - Ibuprofen
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-2144
- Requested NDC
- 51672-2144-01
- Package NDCs from labels
- 51672-2144-8, 51672-2144-1, 51672-2144-01
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc.
- Effective date
- 2025-07-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ibuprofen | Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | 2025-07-07 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-2144-1 | Ibuprofen | 240 mL in 1 BOTTLE | SUSPENSION | 240 | 5 | |
| 51672-2144-1 | Ibuprofen | 1 in 1 CARTON | SUSPENSION | 1 | 5 | |
| 51672-2144-8 | Ibuprofen | 120 mL in 1 BOTTLE | SUSPENSION | 120 | 5 | |
| 51672-2144-8 | Ibuprofen | 1 in 1 CARTON | SUSPENSION | 1 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-2144 | IBUPROFEN SUSPENSION [-SUN PHARMACEUTICAL INDUSTRIES, INC.] | 4 | Current NDC, Legacy NDC, 4 package rows | 20250406_6cf3328b-da8f-4f6b-8237-16a4d6b9c833.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Leader Ibuprofen | IBUPROFEN | Cardinal Health 110, LLC. dba Leader | 63b8d389-7feb-41d2-8970-b7d5660ccb4a | 2025-08-14 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | FSA STORE INC. | ec6b1b86-46fc-7e82-e053-2a95a90ac147 | 2025-08-12 | Warnings | WK2XYI10QM |
| Norms Hemorrhoid | GLYCERIN, LIDOCAINE, PETROLATUM, PHENYLEPHRINE HCL | Totally Normal Company | 3bdf8c74-3db6-1805-e063-6394a90aaba0 | 2025-08-08 | Warnings | PDC6A3C0OX |
| Childrens Ibuprofen | IBUPROFEN | Precision Dose Inc. | fbbc67a7-359f-4155-9367-3815c05ccf03 | 2025-08-08 | Warnings | 197803 WK2XYI10QM |
| Childrens Ibuprofen | IBUPROFEN | Precision Dose Inc. | 59b881f9-1830-4bce-99d2-9770c9b2575f | 2025-08-08 | Warnings | 197803 WK2XYI10QM |
| Ibuprofen | IBUPROFEN | PROSTAT FIRST AID | 3bca27b4-3df6-b7d1-e063-6394a90ac6af | 2025-08-07 | Warnings | WK2XYI10QM |
| Durma DynaGel | DURMA DYNAGEL | Dynarex Corporation | 3bcbe314-98ca-78f1-e063-6394a90a13ad | 2025-08-07 | Warnings | PDC6A3C0OX |
| Ibuprofen | IBUPROFEN | Advanced Rx of Tennessee, LLC | af9ac948-440c-5abf-e053-2995a90af2b5 | 2025-08-07 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Medics Choice Fresh and Soothe | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | Unimed | 3bcd8394-f486-d306-e063-6294a90a4e9a | 2025-08-07 | Warnings | PDC6A3C0OX |
| Ibuprofen | IBUPROFEN | EQUATE (WAL-MART STORES, INC.) | 104b5ac1-9c5e-40f8-a9b1-1761b495bb1c | 2025-08-06 | Warnings | ANDA209207 197803 WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Advanced Rx of Tennessee, LLC | 3b9fdc48-c071-4e2c-e063-6294a90a679f | 2025-08-05 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| CHILDRENS IBUPROFEN | IBUPROFEN | Meijer, Inc. | eed4f13d-4bee-4ccc-a651-a6f86d6d1f7b | 2025-08-04 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Asclemed USA, Inc. | d7ed42c4-371c-4a54-ab15-0630656f0427 | 2025-08-02 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | PHOENIX RX LLC | 3b17587e-b609-42a9-e063-6294a90ab1f8 | 2025-08-01 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Medics Choice Fresh and Soothe | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | KC Pharmaceuticals, Inc. | 3bc03d54-6b31-5921-e063-6294a90af599 | 2025-08-01 | Warnings | PDC6A3C0OX |
| Childrens Ibuprofen Oral Suspension | IBUPROFEN | PAI Holdings, LLC dba PAI Pharma | c26cefe0-182a-4b03-baeb-b3eb2e0e2267 | 2025-08-01 | Warnings | 197803 WK2XYI10QM |
| Ibuprofen and famotidine | IBUPROFEN AND FAMOTIDINE | Preferred Pharmaceuticals Inc. | e2f29ca9-9ec8-4b82-8c80-8628d9e3ab2f | 2025-08-01 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Acetaminophen, Ibuprofen | ACETAMINOPHEN, IBUPROFEN | GLENMARK THERAPEUTICS INC., USA | 57a8dc2b-a3bc-49fa-b605-2330155bdbff | 2025-07-31 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 0e95aab9-3a7c-49c3-b8df-f66d6f31aee0 | 2025-07-31 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Rite Aid Corporation | 47657d95-4a54-49c2-8273-86b413b8f41e | 2025-07-30 | Warnings | WK2XYI10QM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.